{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:31:33Z","timestamp":1773239493839,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clinthera.2021.05.010","type":"journal-article","created":{"date-parts":[[2021,6,12]],"date-time":"2021-06-12T06:38:01Z","timestamp":1623479881000},"page":"942-952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Unexpected Findings During Double-blind Discontinuation of Acetylcholinesterase Inhibitor Medications"],"prefix":"10.1016","volume":"43","author":[{"given":"Lauren R.","family":"Moo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalpana","family":"Padala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan A.","family":"Dunay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael R.","family":"Scali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunny","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Thielke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2021.05.010_bib0001","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s40266-015-0266-9","article-title":"A risk-benefit assessment of dementia medications: systematic review of the evidence","volume":"32","author":"Buckley","year":"2015","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0002","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/ggi.13177","article-title":"Donepezil is associated with decreased in-hospital mortality as a result of pneumonia among older patients with dementia: A retrospective cohort study","volume":"18","author":"Abe","year":"2018","journal-title":"Geriatr Gerontol Int"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0003","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ageing\/afu143","article-title":"Systematic review of recent dementia practice guidelines","volume":"44","author":"Ngo","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0004","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/YIC.0b013e3283339496","article-title":"Eight-year prescription trends of memantine and cholinesterase inhibitors among persons 65 years and older in Germany","volume":"25","author":"Hoffmann","year":"2010","journal-title":"Int Clin Psychopharm"},{"issue":"21","key":"10.1016\/j.clinthera.2021.05.010_sbref0018","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16210","article-title":"The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model","volume":"16","author":"Bond","year":"2012","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0005","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1159\/000441894","article-title":"Donepezil adherence, persistence and time to first discontinuation in a three-year follow-up of older people","volume":"5","author":"Ndukwe","year":"2015","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0006","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4140\/TCP.n.2018.273.","article-title":"The impact of cholinesterase inhibitors with or without memantine on antipsychotic prescribing","volume":"33","author":"Blaszczyk","year":"2018","journal-title":"Consult Pharm"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0007","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/alz.12054","article-title":"Impact of deprescribing AChEIs on aggressive behaviors and antipsychotic prescribing","volume":"16","author":"Niznik","year":"2020","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0008","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1111\/jgs.15985","article-title":"Factors associated with deprescribing acetylcholinesterase inhibitors in older nursing home residents with severe dementia","volume":"67","author":"Niznik","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0009","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jagp.2017.09.027","article-title":"A systematic review of practice guidelines and recommendations for discontinuation of cholinesterase inhibitors in dementia","volume":"26","author":"Renn","year":"2018","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0010","doi-asserted-by":"crossref","first-page":"174","DOI":"10.5694\/mja2.50015","article-title":"Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary","volume":"210","author":"Reeve","year":"2019","journal-title":"Med J Aust"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0011","article-title":"Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia Cochrane","volume":"2","author":"Parsons","year":"2021","journal-title":"Database Syst Rev"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0012","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S1474-4422(15)00258-6","article-title":"Nursing home placement in the donepezil and memantine in moderate to severe Alzheimer's disease (DOMINO-AD) trial: secondary and post-hoc analyses","volume":"14","author":"Howard","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006504.pub2","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease","author":"Rolinski","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0014","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jnnp-2014-307659","article-title":"Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis","volume":"86","author":"Wang","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp-2014-308764","article-title":"Cholinesterase inhibitors for Parkinson's disease: a systematic review and meta-analysis","volume":"86","author":"Pagano","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0016","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1474-4422(15)00389-0","article-title":"Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"15","author":"Henderson","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0017","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12883-015-0523-x","article-title":"Effect of augmenting cholinergic function on gait and balance","volume":"15","author":"Mancini","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0018","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1532-5415.2011.03450.x","article-title":"Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials","volume":"59","author":"Kim","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0019","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/gps.995","article-title":"What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia","volume":"18","author":"Minett","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0020","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00005650-200209000-00007","article-title":"Six-item screener to identify cognitive impairment among potential subjects for clinical research","volume":"40","author":"Callahan","year":"2002","journal-title":"Med Care"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2021.05.010_bib0021","first-page":"301","article-title":"Behavioral pathology in Alzheimer's disease (BEHAVE-AD) rating scale","volume":"8","author":"Reisberg","year":"1996","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0022","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1017\/S1355617705050502","article-title":"Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease","volume":"11","author":"Galasko","year":"2005","journal-title":"J Int Neuropsychol Soc"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0023","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/geront\/41.5.652","article-title":"The Zarit Burden Interview: a new short version and screening version","volume":"41","author":"Bedard","year":"2001","journal-title":"Gerontologist"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0024","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.mayocp.2020.06.058","article-title":"Disparities in research participation by level of health literacy","volume":"96","author":"Kripalani","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0025","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1567205016666190321161901","article-title":"Strategies for the recruitment and retention of racial\/ethnic minorities in alzheimer disease and dementia clinical research","volume":"16","author":"Wong","year":"2019","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0026","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1474-4422(16)00003-X","article-title":"Acetylcholinesterase inhibitors and gait: a steadying hand?","volume":"15","author":"Moreau","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0027","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/1099-1166(200009)15:9<794::AID-GPS178>3.0.CO;2-1","article-title":"Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study","volume":"15","author":"Samuel","year":"2000","journal-title":"Int J Geriatric Psychiatry"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0028","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0029","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00002826-199508000-00004","article-title":"A longitudinal study of the effects of an L-dopa drug holiday on the course of Parkinson's disease","volume":"18","author":"Corona","year":"1995","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0030","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/mds.21448","article-title":"drug holiday\" with amantadine infusions as a treatment of complications in Parkinson's disease","volume":"22","author":"Koziorowski","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0031","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jnnp.2004.050682","article-title":"Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study","volume":"76","author":"Ravina","year":"2005","journal-title":"J Neurol Neurosur Psychiatry"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0032","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000017126","article-title":"The effects of donepezil in Alzheimer's disease\u2014results from a multinational trial","volume":"10","author":"Burns","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.clinthera.2021.05.010_bib0033","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/ageing\/afaa008","article-title":"Symptoms of mood disorders in family carers of older people with dementia who experience caregiver burden: a network approach","volume":"49","author":"Franca","year":"2020","journal-title":"Age Ageing"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821002253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821002253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:55:27Z","timestamp":1758963327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291821002253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0149291821002253"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.05.010","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unexpected Findings During Double-blind Discontinuation of Acetylcholinesterase Inhibitor Medications","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}